118 related articles for article (PubMed ID: 37922621)
1. Inflammation and comorbidities of chronic obstructive pulmonary disease: The cytokines put on a mask!
Long J; Xu P; Chen J; Liao J; Sun D; Xiang Z; Ma H; Duan H; Ju M; Ouyang Y
Cytokine; 2023 Dec; 172():156404. PubMed ID: 37922621
[TBL] [Abstract][Full Text] [Related]
2. Multiple Factor Analysis of Depression and/or Anxiety in Patients with Acute Exacerbation Chronic Obstructive Pulmonary Disease.
Long J; Ouyang Y; Duan H; Xiang Z; Ma H; Ju M; Sun D
Int J Chron Obstruct Pulmon Dis; 2020; 15():1449-1464. PubMed ID: 32606653
[TBL] [Abstract][Full Text] [Related]
3. Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
Liao QQ; Mo YJ; Zhu KW; Gao F; Huang B; Chen P; Jing FT; Jiang X; Xu HZ; Tang YF; Chu LW; Huang HL; Wang WL; Wei FN; Huang DD; Zhao BJ; Chen J; Zhang H
Int J Chron Obstruct Pulmon Dis; 2024; 19():501-518. PubMed ID: 38414718
[TBL] [Abstract][Full Text] [Related]
4. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
[TBL] [Abstract][Full Text] [Related]
5. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
6. Serum Biomarkers in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Comparative Study.
Şahin F; Koşar AF; Aslan AF; Yiğitbaş B; Uslu B
J Med Biochem; 2019 Oct; 38(4):503-511. PubMed ID: 31496916
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study.
Günay E; Sarınç Ulaşlı S; Akar O; Ahsen A; Günay S; Koyuncu T; Unlü M
Inflammation; 2014 Apr; 37(2):374-80. PubMed ID: 24078279
[TBL] [Abstract][Full Text] [Related]
8. Impact of Combined Chronic Obstructive Pulmonary Disease Status and Systemic Inflammation on Outcome of Advanced NSCLC: Multicenter Retrospective Cohort Study.
Lim JU; Kang HS; Yeo CD; Kim JS; Park CK; Kim YH; Kim JW; Kim SJ; Lee SH
Int J Chron Obstruct Pulmon Dis; 2020; 15():3323-3334. PubMed ID: 33363365
[TBL] [Abstract][Full Text] [Related]
9. Are Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios Prognostic Indicators in Patients With Chronic Obstructive Pulmonary Disease in Intensive Care Units?
Eraslan Doganay G; Cirik MO
Cureus; 2022 Mar; 14(3):e23499. PubMed ID: 35494932
[TBL] [Abstract][Full Text] [Related]
10. Uric acid and uric acid to creatinine ratio in the assessment of chronic obstructive pulmonary disease: Potential biomarkers in multicomponent models comprising IL-1beta.
Rumora L; Hlapčić I; Popović-Grle S; Rako I; Rogić D; Čepelak I
PLoS One; 2020; 15(6):e0234363. PubMed ID: 32502184
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease.
Perrotta F; Nigro E; Pafundi PC; Polito R; Nucera F; Scialò F; Caramori G; Bianco A; Daniele A
COPD; 2021 Feb; 18(1):70-75. PubMed ID: 33302720
[TBL] [Abstract][Full Text] [Related]
12. The role of the serum IL-33/sST2 axis and inflammatory cytokines in chronic obstructive pulmonary disease.
Tang Y; Guan Y; Liu Y; Sun J; Xu L; Jiang Y
J Interferon Cytokine Res; 2014 Mar; 34(3):162-8. PubMed ID: 24102578
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
14. Monocyte to Lymphocyte Ratio, Neutrophil to Lymphocyte Ratio, and Red Cell Distribution Width are the Associates with Gouty Arthritis.
Kadiyoran C; Zengin O; Cizmecioglu HA; Tufan A; Kucuksahin O; Cure MC; Cure E; Kucuk A; Ozturk MA
Acta Medica (Hradec Kralove); 2019; 62(3):99-104. PubMed ID: 31663502
[TBL] [Abstract][Full Text] [Related]
15. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.
Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A
Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426
[TBL] [Abstract][Full Text] [Related]
16. Platelet indices in stable chronic obstructive pulmonary disease - association with inflammatory markers, comorbidities and therapy.
Hlapčić I; Somborac-Bačura A; Popović-Grle S; Vukić Dugac A; Rogić D; Rako I; Žanić Grubišić T; Rumora L
Biochem Med (Zagreb); 2020 Feb; 30(1):010701. PubMed ID: 31839721
[TBL] [Abstract][Full Text] [Related]
17. Relationship between monocytes to lymphocytes ratio and axial spondyloarthritis.
Huang Y; Deng W; Zheng S; Feng F; Huang Z; Huang Q; Guo X; Huang Z; Huang X; Pan X; Li T
Int Immunopharmacol; 2018 Apr; 57():43-46. PubMed ID: 29471252
[TBL] [Abstract][Full Text] [Related]
18. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
19. Mean platelet volume combined red cell distribution width as biomarker of chronic obstructive pulmonary disease with pulmonary heart disease.
Bai Y; Tao XN
Clin Respir J; 2020 Dec; 14(12):1122-1130. PubMed ID: 32772499
[TBL] [Abstract][Full Text] [Related]
20. Can red blood cell distribution width (RDW) level predict the severity of acute exacerbation of chronic obstructive pulmonary disease (AECOPD)?
Alparslan Bekir S; Tuncay E; Gungor S; Yalcinsoy M; Sogukpinar Ö; Gundogus B; Aksoy E; Agca M; Agca Altunbey S; Turker H; Karakurt Z
Int J Clin Pract; 2021 Nov; 75(11):e14730. PubMed ID: 34383359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
